Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Progyny (PGNY) stocks
Learn how to easily invest in Progyny stocks.
Progyny (PGNY) is a leading health information services business based in the US. It opened the day at $59.85 after a previous close of $59.55. During the day the price has varied from a low of $59.25 to a high of $61.96. The latest price was $61.93 (25 minute delay). Progyny is listed on the NASDAQ and employs 311 staff. All prices are listed in US Dollars.
How to buy stocks in Progyny
- Compare stock trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – PGNY – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of stocks with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
- Can I buy shares in Progyny?
- Has coronavirus impacted Progyny shares?
- Progyny shares summary
- Compare share dealing platforms
- Is Progyny stock a buy or sell?
- Progyny performance over time
- Are Progyny shares over-valued?
- Progyny's financials
- How volatile are Progyny shares?
- Does Progyny pay a dividend?
- Other common questions
Progyny stock price (NASDAQ:PGNY)Use our graph to track the performance of PGNY stocks over time.
Progyny shares at a glance
|52-week range||$25.67 - $68.32|
|50-day moving average||$31.59|
|200-day moving average||$42.00|
|Wall St. target price||$62.50|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$0.50|
Compare stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy Progyny stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Progyny price performance over time
|1 week (2022-08-05)||50.50%|
|1 month (2022-07-14)||113.99%|
|3 months (2022-05-11)||87.33%|
|6 months (2022-02-10)||N/A|
|1 year (2021-08-13)||34.25%|
|2 years (2020-08-14)||108.80%|
|3 years (2019-08-10)||N/A|
|5 years (2017-08-10)||N/A|
Is Progyny under- or over-valued?
Valuing Progyny stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Progyny's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Progyny's P/E ratio
Progyny's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 90x. In other words, Progyny shares trade at around 90x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Progyny's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $19 million.
The EBITDA is a measure of a Progyny's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$617.1 million|
|Operating margin TTM||2.86%|
|Gross profit TTM||$112.1 million|
|Return on assets TTM||2.85%|
|Return on equity TTM||17.7%|
|Market capitalisation||$4.1 billion|
TTM: trailing 12 months
Progyny share dividends
We're not expecting Progyny to pay a dividend over the next 12 months.
Progyny share price volatility
Over the last 12 months, Progyny's shares have ranged in value from as little as $25.67 up to $68.32. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Progyny's is 1.85. This would suggest that Progyny's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Progyny, Inc. , a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc.
Stocks similar to Progyny
Progyny in the news
AMN vs. PGNY: Which Stock Should Value Investors Buy Now?
Barron’s Stock Picks Had a Good Week. Progyny, Angi, and Other Stocks That Outperformed the Market.
ClearBridge Investments Observes Progyny, Inc. (PGNY) as Underpenetrated in its Market
Frequently asked questions
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
More on investing
You can’t buy NFL stock directly, but you can invest in companies that back the football industry.Read more…
Compare 15 of the best stock picking services, and learn how to choose the best option for your needs.Read more…
Here are the best Canadian investment newsletters to help you boost your investment knowledge and grow your wealth.Read more…
More guides on Finder
How to buy GigaCloud Technology Inc. (GCT) stock in Canada when it goes public
Everything we know about the GigaCloud Technology Inc. IPO plus information on how to buy in.
How to buy Starbox Group Holdings Ltd. (STBX) stock in Canada when it goes public
Everything we know about the Starbox Group Holdings Ltd. IPO plus information on how to buy in.
How to buy Magic Empire Global stock in Canada
Steps to owning and managing MEGL stock, with 24-hour and historical pricing before you buy.
How to buy QuantumScape stock in Canada
Steps to owning and managing QS stock, with 24-hour and historical pricing before you buy.
How to buy Bruush Oral Care (BRSH) stock in Canada when it goes public
Everything we know about the Bruush Oral Care IPO plus information on how to buy in.
How to buy Loop Media (LPTV) stock in Canada when it goes public
Everything we know about the Loop Media IPO plus information on how to buy in.
7 tips for trading stocks
Are you looking to start stock trading? Here’s our top 7 tips to help you begin.
How to buy Savage X Fenty stock in Canada when it goes public
Everything we know about the Savage X Fenty IPO plus information on how to buy in.
FTSE 100 vs S&P 500
Find out the key differences between the FTSE 100 and the S&P 500.
How to buy DeLorean Motor Company stock in Canada when it goes public
Everything we know about the DeLorean Motor Company IPO plus information on how to buy in.
Ask an Expert
You must be logged in to post a comment.